Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR2 | P25025 | 20/20 | 1.00 |
| ▸ | CX3CR1 | P49238 | 3/20 | 0.83 |
| ▸ | HTR1B | P28222 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29366739 | 1.00 | CXCR2 (1.00) | CXCR2CX3CR1HTR1B | |
| SCHEMBL29501084 | 1.00 | CXCR2 (1.00) | CXCR2CX3CR1HTR1B | |
| SCHEMBL841617 | 0.99 | CXCR2 (0.98) | CXCR2CX3CR1HTR1B | |
| SCHEMBL841616 | 0.99 | CXCR2 (0.98) | CXCR2CX3CR1HTR1B | |
| SCHEMBL842403 | 0.93 | CXCR2 (1.00) | CXCR2CX3CR1HTR1B | |
| SCHEMBL841935 | 0.92 | CXCR2 (0.85) | CXCR2CX3CR1HTR1B | |
| SCHEMBL25298324 | 0.91 | CXCR2 (1.00) | CXCR2CX3CR1HTR1B | |
| SCHEMBL5036208 | 0.91 | CXCR2 (1.00) | CXCR2CX3CR1HTR1B | |
| SCHEMBL4711342 | 0.91 | CXCR2 (0.83) | CXCR2CX3CR1HTR1B | |
| SCHEMBL841838 | 0.91 | CXCR2 (0.83) | CXCR2CX3CR1HTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4140486-A1 | METHODS AND COMPOUNDS FOR THE ALLEVIATION AND/OR PREVENTION OF PAIN | Klareskog, Lars (SE) | 2023-03-01 | — | — | EP | claimed |
| EP-3316886-B1 | METHODS AND COMPOUNDS FOR THE ALLEVIATION AND/OR PREVENTION OF PAIN | SVENSSON CAMILLA (SE) | 2022-05-18 | — | — | EP | claimed |
| US-20170181987-A1 | INHIBITION OF IL-8 IN THE TREATMENT OF PAIN AND/OR BONE LOSS | SVENSSON CAMILLA (SE) | 2017-06-29 | — | — | US | claimed |
| US-8143261-B2 | Thiazolo (4,5-D) pyrimidine compounds | ASTRAZENECA AB (SE) | 2012-03-27 | — | — | US | claimed |
| US-20100217000-A1 | Process for the Preparation of Thiazolopyrimidines | ASTRAZENECA AB (SE) | 2010-08-26 | — | — | US | claimed |
| US-20090281123-A1 | NOVEL THIAZOLO (4,5-D) PYRIMIDINE COMPOUNDS NOVEL COMPOUNDS | ASTRAZENECA UK LIMITED | 2009-11-12 | — | — | US | claimed |
| US-20090043097-A1 | Methods | ASTRAZENECA AB (SE) | 2009-02-12 | — | — | US | claimed |
| EP-1348709-B1 | Thiazolo[4,5-d]pyrimidine compounds for the treatment of rheumatoid arthritis | ASTRAZENECA UK LTD (GB) | 2008-01-16 | — | — | EP | claimed |
| US-20070282103-A1 | Process for the Preparation of Thiazolopyrimidines | ASTRAZENECA AB (SE) | 2007-12-06 | — | — | US | claimed |
| US-20040224961-A1 | Novel thiazolo (4,5-D) pyrimidine compounds | ASTRAZENECA UK LIMITED, A BRITISH CORPORATION | 2004-11-11 | — | — | US | claimed |
| US-6790850-B1 | Thiazolo(4,5-d)pyrimidine compounds | ASTRAZENECA UK LIMITED (GB) | 2004-09-14 | — | — | US | claimed |
| EP-1222195-B1 | NOVEL THIAZOLO(4,5-D)PYRIMIDINE COMPOUNDS | ASTRAZENECA UK LTD (GB) | 2004-01-14 | — | — | EP | claimed |
| EP-1348709-A2 | Thiazolo (4,5-D) pyrimidine compounds | AstraZeneca UK Limited (GB) | 2003-10-01 | — | — | EP | claimed |
| US-20230210792-A1 | USE OF A COMBINATION OF COLCHICINE AND A CXCR-2 INHIBITORS FOR THE TREATMENT OR PREVENTION OF FAMILIAL MEDITERRANEAN FEVER (FMF) AND FLARE-UPS THEREOF | ARISTEA THERAPEUTICS, INC. | 2023-07-06 | — | — | US | disclosed |
| EP-4140486-A1 | METHODS AND COMPOUNDS FOR THE ALLEVIATION AND/OR PREVENTION OF PAIN | Klareskog, Lars (SE) | 2023-03-01 | — | — | EP | disclosed |
| EP-3316886-B1 | METHODS AND COMPOUNDS FOR THE ALLEVIATION AND/OR PREVENTION OF PAIN | SVENSSON CAMILLA (SE) | 2022-05-18 | — | — | EP | disclosed |
| US-20040224961-A1 | Novel thiazolo (4,5-D) pyrimidine compounds | ASTRAZENECA UK LIMITED, A BRITISH CORPORATION | 2004-11-11 | — | — | US | disclosed |
| US-6790850-B1 | Thiazolo(4,5-d)pyrimidine compounds | ASTRAZENECA UK LIMITED (GB) | 2004-09-14 | — | — | US | disclosed |
| EP-1222195-B1 | NOVEL THIAZOLO(4,5-D)PYRIMIDINE COMPOUNDS | ASTRAZENECA UK LTD (GB) | 2004-01-14 | — | — | EP | disclosed |
| EP-1348709-A2 | Thiazolo (4,5-D) pyrimidine compounds | AstraZeneca UK Limited (GB) | 2003-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090043097-A1 | Methods | CYP21A2, CYP17A1, HSD17B7 | CXCR2 2692/4885CX3CR1 4623/4885HTR1B 2485/4885 |
| US-20070282103-A1 | Process for the Preparation of Thiazolopyrimidines | TPMT, TYMP, DPYD | CXCR2 2764/4885CX3CR1 4576/4885HTR1B 2530/4885 |
| US-20040224961-A1 | Novel thiazolo (4,5-D) pyrimidine compounds | TYMS, DPYD, TYMP | CXCR2 378/4885CX3CR1 2551/4885HTR1B 2100/4885 |
| US-20230210792-A1 | USE OF A COMBINATION OF COLCHICINE AND A CXCR-2 INHIBITORS FOR THE TREATMENT OR PREVENTION OF FAMILIAL MEDITERRANEAN FEVER (FMF) AND FLARE-UPS THEREOF | CXCR1, CXCR2, FPR2 | CXCR2 2/4885CX3CR1 17/4885HTR1B 568/4885 |
| US-20090281123-A1 | NOVEL THIAZOLO (4,5-D) PYRIMIDINE COMPOUNDS NOVEL COMPOUNDS | TYMS, DPYD, TPMT | CXCR2 195/4885CX3CR1 2122/4885HTR1B 2520/4885 |
| US-20100217000-A1 | Process for the Preparation of Thiazolopyrimidines | TPMT, TYMP, DPYD | CXCR2 2645/4885CX3CR1 4479/4885HTR1B 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.